{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:27:33Z","timestamp":1777015653029,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jsat.2020.108197","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:31:16Z","timestamp":1606170676000},"page":"108197","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic"],"prefix":"10.1016","volume":"121","author":[{"given":"Kelly E.","family":"Dunn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Brooner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth B.","family":"Stoller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2020.108197_bb0005","series-title":"Mental Health Services Administration, 2017. National Survey of Substance Abuse Treatment Services (N-SSATS): 2015. Data on substance abuse treatment facilities. BHSIS series S-88, HHS publication no. (SMA) 17\u20135031","author":"Abuse","year":"2017"},{"key":"10.1016\/j.jsat.2020.108197_bb0010","article-title":"Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine\/naloxone","author":"Antoine","year":"2020","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.jsat.2020.108197_bb0015","article-title":"When epidemics collide: Coronavirus disease 2019 (COVID-19) and the opioid crisis","volume":"M20-1210","author":"Becker","year":"2020","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1016\/j.jsat.2020.108197_bb0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.dsx.2020.06.008","article-title":"COVID-19 and addiction","volume":"14","author":"Dubey","year":"2020","journal-title":"Diabetes & Metabolic Syndrome"},{"issue":"1","key":"10.1016\/j.jsat.2020.108197_bb0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12954-020-00370-7","article-title":"Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic","volume":"17","author":"Dunlop","year":"2020","journal-title":"Harm Reduction Journal"},{"issue":"2","key":"10.1016\/j.jsat.2020.108197_bb0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/08897077.2020.1752351","article-title":"Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment","volume":"41","author":"Green","year":"2020","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2020.108197_bb0035","doi-asserted-by":"crossref","first-page":"107515","DOI":"10.1016\/j.drugalcdep.2019.06.017","article-title":"Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder","volume":"204","author":"Gryczynski","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2020.108197_bb0040","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2020.108197_bb0045","doi-asserted-by":"crossref","DOI":"10.1037\/tra0000660","article-title":"COVID-19, mental health, and opioid use disorder: Old and new public health crises intertwine","author":"Henry","year":"2020","journal-title":"Psychological Trauma Theory Research Practice and Policy"},{"key":"10.1016\/j.jsat.2020.108197_bb0050","doi-asserted-by":"crossref","first-page":"108147","DOI":"10.1016\/j.drugalcdep.2020.108147","article-title":"Protracted renal clearance of fentanyl in persons with opioid use disorder","volume":"214","author":"Huhn","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.jsat.2020.108197_bb0055","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2020.108197_bb0060","doi-asserted-by":"crossref","DOI":"10.1037\/tra0000622","article-title":"Commentary on the coronavirus pandemic: Anticipating a fourth wave in the opioid epidemic","author":"McCann Pineo","year":"2020","journal-title":"Psychological Trauma Theory Research Practice and Policy"},{"key":"10.1016\/j.jsat.2020.108197_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsat.2018.10.007","article-title":"Fentanyl exposure among patients seeking opioid treatment","volume":"96","author":"Ochalek","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"25","key":"10.1016\/j.jsat.2020.108197_bb0070","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1610047","article-title":"Interim buprenorphine vs. waiting list for opioid dependence","volume":"375","author":"Sigmon","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2020.108197_bb0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugpo.2019.09.003","article-title":"\u201cEverything is not right anymore\u201d: Buprenorphine experiences in an era of illicit fentanyl","volume":"74","author":"Silverstein","year":"2019","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2020.108197_bb0085","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)"},{"issue":"5","key":"10.1016\/j.jsat.2020.108197_bb0090","first-page":"368","article-title":"Increases in body mass index and cardiovascular risk factors during methadone maintenance treatment","volume":"15","author":"Sweeney","year":"2019","journal-title":"Journal of Opioid Management"},{"key":"10.1016\/j.jsat.2020.108197_bb0095","doi-asserted-by":"crossref","DOI":"10.7326\/M20-1212","article-title":"Collison of the COVID-19 and addiction epidemics","author":"Volkow","year":"2020","journal-title":"Annals of Internal Medicine"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220304542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220304542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:52:41Z","timestamp":1760039561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547220304542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":18,"alternative-id":["S0740547220304542"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108197","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108197"}}